# Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis

> **NCT04331327** · PHASE2 · COMPLETED · sponsor: **Rasmia Elgohary** · enrollment: 31 (actual)

## Conditions studied

- Osteo Arthritis Knee

## Interventions

- **DRUG:** allogenic lyophilized growth factors

## Key facts

- **NCT ID:** NCT04331327
- **Lead sponsor:** Rasmia Elgohary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-04-28
- **Final completion:** 2018-04-28
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04331327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04331327, "Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04331327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*